FDA
approval
· 2017-03-28
FDA Approved: ABACAVIR AND LAMIVUDINE — Original Application (Lupin Pharmaceuticals, Inc.)
Summary
FDA approved Lupin Pharmaceuticals' generic fixed-dose combination tablet of abacavir and lamivudine. It is indicated for the treatment of HIV-1 infection in co…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ABACAVIR AND LAMIVUDINE (ABACAVIR AND LAMIVUDINE)